Application of xCELLigence RTCA Biosensor Technology for Revealing the Profile and Window of Drug Responsiveness in Real Time.

Biosensors (Basel) · 2015 · PMC4493546 · PMID 25893878

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

almost insignificantno p-value reported

Like any technology, xCELLigence has limitations, but these are almost insignificant to its potential.

also in 529 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.